Direkt zum Inhalt
Merck
  • Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.

Uptake and effects of a mixture of widely used therapeutic drugs in Eruca sativa L. and Zea mays L. plants.

Ecotoxicology and environmental safety (2014-07-22)
Milena Marsoni, Fabrizio De Mattia, Massimo Labra, Antonia Bruno, Antonella Bruno, Marcella Bracale, Candida Vannini
ZUSAMMENFASSUNG

Pharmaceutically active compounds (PACs) are continuously dispersed into the environment due to human and veterinary use, giving rise to their potential accumulation in edible plants. In this study, Eruca sativa L. and Zea mays L. were selected to determine the potential uptake and accumulation of eight different PACs (Salbutamol, Atenolol, Lincomycin, Cyclophosphamide, Carbamazepine, Bezafibrate, Ofloxacin and Ranitidine) designed for human use. To mimic environmental conditions, the plants were grown in pots and irrigated with water spiked with a mixture of PACs at concentrations found in Italian wastewaters and rivers. Moreover, 10× and 100× concentrations of these pharmaceuticals were also tested. The presence of the pharmaceuticals was tested in the edible parts of the plants, namely leaves for E. sativa and grains for Z. mays. Quantification was performed by liquid chromatography mass spectroscopy (LC/MS/MS). In the grains of 100× treated Z. mays, only atenolol, lincomycin and carbamazepine were above the limit of detection (LOD). At the same concentration in E. sativa plants the uptake of all PACs was >LOD. Lincomycin and oflaxacin were above the limit of quantitation in all conditions tested in E. sativa. The results suggest that uptake of some pharmaceuticals from the soil may indeed be a potential transport route to plants and that these environmental pollutants can reach different edible parts of the selected crops. Measurements of the concentrations of these pharmaceuticals in plant materials were used to model potential adult human exposure to these compounds. The results indicate that under the current experimental conditions, crops exposed to the selected pharmaceutical mixture would not have any negative effects on human health. Moreover, no significant differences in the growth of E. sativa or Z. mays plants irrigated with PAC-spiked vs. non-spiked water were observed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Carbamazepin, powder
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Lincomycin -hydrochlorid, 96.0-102.0% (HPLC)
Sigma-Aldrich
Ranitidin -hydrochlorid, solid
Sigma-Aldrich
Bezafibrat, ≥98%, solid
Sigma-Aldrich
Lincomycin -hydrochlorid, ≥90% (TLC)
Supelco
Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Albuterolsulfat, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Carbamazepin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Lincomycin -hydrochlorid, BioReagent, suitable for cell culture
Supelco
Carbamazepin, analytical standard
Supelco
Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Salbutamol hemisulfate salt, ≥98%
USP
Atenolol, United States Pharmacopeia (USP) Reference Standard
Supelco
Ranitidin -hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Lincomycin-Hydrochlorid, United States Pharmacopeia (USP) Reference Standard
Supelco
Ofloxacin, VETRANAL®, analytical standard
Supelco
Lincomycin -hydrochlorid Monohydrat, VETRANAL®, analytical standard
Salbutamolsulfat, European Pharmacopoeia (EP) Reference Standard
USP
Carbamazepin, United States Pharmacopeia (USP) Reference Standard
USP
Ranitidin -hydrochlorid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Carbamazepin, meets USP testing specifications
Lincomycin-Hydrochlorid, European Pharmacopoeia (EP) Reference Standard
Carbamazepin, European Pharmacopoeia (EP) Reference Standard